Wijsenbeek MS, Floricel F, Thonnard J, et al. A worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries. ERS 2018, Parijs. Sessie 46; OA263.
Icotinib versus chemotherapie als adjuvante behandeling stadium II-IIIA EGFR-gemuteerd NSCLC
jan 2022 | Longoncologie